The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Astone Capital VCC - Arven & Astone Capital VCC - Alpha A2
AHCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Astone Capital VCC – Arven and Astone Capital VCC – Alpha A2, two Singapore-based funds acting in concert, acquired 49,30,241 equity shares (9.28%) of Anlon Healthcare Ltd through the company's public issue (IPO) on 1st September 2025. Before this acquisition, the funds held no shares in the company, so they went from zero to a 9.28% stake in one transaction. The acquirer is not part of the promoter/promoter group. Anlon Healthcare's total equity share capital stands at 53,151,500 shares, unchanged by the acquisition since this was an IPO allotment. The filing was made on 2nd September 2025 from Singapore.
The 9.28% stake signals meaningful institutional (likely foreign) investor interest in Anlon Healthcare's IPO. Holding is just under the 10% SAST threshold, so any further acquisition could trigger an open offer obligation for the buyer. Shareholders should monitor for any additional stake build-up by this investor.